Table 2 Baseline characteristics of the study population based on PONV score after PSM.
Variables | Control (n = 47) | Mild (n = 29) | Moderate (n = 11) | Severe (n = 7) | p Value |
|---|---|---|---|---|---|
Demographics | |||||
Age | 35 (26–44) | 38 (22.5–66.5) | 31 (25–35) | 45 (33–76) | < 0.05 |
Gender(%male) | 22 (47%) | 16 (55%) | 4 (36%) | 6 (86%) | 0.18 |
BMI (kg/m2) | 36.8 (25.0–42.4) | 26.6 (24.6–41.0) | 33.3 (23.1–47.1) | 25.4 (19.7–26.9) | 0.17 |
Smoking (%) | 25 (53%) | 12 (48%) | 6 (55%) | 5 (71%) | 0.75 |
Hospital stay | 10 (8–11) | 9 (9–13) | 10 (10–14) | 10 (9–12) | 0.16 |
T2D (%) | 24 (51%) | 13 (45%) | 4 (36%) | 2 (29%) | 0.62 |
GERD (%) | 23 (49%) | 16 (64%) | 6 (55%) | 1 (14%) | 0.21 |
PONV HIS (%) | 41 (87%) | 25 (86%) | 7 (64%) | 7 (100%) | 0.14 |
Motion HIS (%) | 30 (64%) | 21 (72%) | 10 (91%) | 4 (57%) | 0.29 |
Laboratory test | |||||
NLR | 1.16 (1.08–1.57) | 1.60 (1.44–1.80) | 2.14 (1.81–2.70) | 3.10 (3.03–3.46) | < 0.01 |
MLR | 1.67 (1.38–2.11) | 1.47 (1.16–1.87) | 1.94 (1.85–2.02) | 2.11 (1.65–2.87) | 0.31 |
Operation (LSG%) | 24 (51%) | 10 (34%) | 7 (64%) | 1 (14%) | 0.11 |
Operation time | 165 (150–210) | 180 (162–215) | 157 (120–190) | 180 (150–270) | 0.21 |
PCIA | 32 (68%) | 19 (66%) | 10 (91%) | 7 (100%) | 0.13 |
Opioid | 16 (34%) | 9 (31%) | 7 (64%) | 5 (71%) | 0.07 |
Anisodamine | 15 (32%) | 10 (34%) | 6 (55%) | 4 (57%) | 0.35 |
Ondansetron | 13 (28%) | 3 (10%) | 8 (73%) | 2 (29%) | < 0.01 |
